Related Experiment Videos
Normotest and abnormal prothrombin in liver transplantation
1Department of Surgery, University of Pittsburgh School of Medicine, PA, USA.
Liver
|October 1, 1995
Summary
Liver transplantation outcomes were assessed using Normotest and des-gamma-carboxy prothrombin levels. These markers effectively indicate liver graft function and rejection post-transplant, aiding clinical outcome prediction.
Area of Science:
- Hepatology
- Transplantation immunology
- Clinical biochemistry
Background:
- Postoperative monitoring of liver transplant recipients is crucial for assessing graft function and detecting rejection.
- Coagulation parameters, particularly abnormal prothrombin levels, can offer insights into hepatic health.
Purpose of the Study:
- To evaluate postoperative changes in coagulation parameters, specifically Normotest and des-gamma-carboxy prothrombin, after liver transplantation.
- To correlate these coagulation markers with clinical outcomes, including graft function and rejection severity.
Main Methods:
- Analysis of coagulation parameters (Normotest, des-gamma-carboxy prothrombin) in 95 liver transplant patients.
- Classification of patients into groups based on postoperative course and graft survival.
- Comparison of coagulation marker levels with liver biopsy histology in cases of acute cellular rejection.
Main Results:
- Normotest levels reflected liver graft function, increasing with good function and decreasing with early graft failure (Group IV).
- Elevated des-gamma-carboxy prothrombin levels correlated with severe acute cellular rejection.
- Low des-gamma-carboxy prothrombin levels were observed in grafts with early failure.
Conclusions:
- Normotest and des-gamma-carboxy prothrombin are valuable biomarkers for assessing hepatic function post-liver transplantation.
- These parameters aid in the early detection of graft dysfunction and rejection, correlating with clinical outcomes.